Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Toll-like receptor signaling pathway	9/104	6.765056927331473e-17	5.953250096051696e-15	755.3368421052631	-573.3131614769173	IFNA1;MYD88;NFKB1;TLR2;TLR3;TLR4;TLR7;TLR9;TRAF6
KEGG_2021_Human	Measles	8/139	2.745876928861639e-13	1.2081858486991212e-11	242.35114503816794	-438.49678811588683	IFNA1;MYD88;NFKB1;TLR2;TLR4;TLR7;TLR9;TRAF6
KEGG_2021_Human	Coronavirus disease	8/232	1.7599698728274597e-11	5.162578293627215e-10	140.07142857142858	-334.06967394373197	IFNA1;MYD88;NFKB1;TLR2;TLR3;TLR4;TLR7;TRAF6
KEGG_2021_Human	Hepatitis B	7/162	1.3081178790339969e-10	2.877859333874793e-09	119.12043010752689	-340.5301663464764	IFNA1;MYD88;NFKB1;TLR2;TLR3;TLR4;TRAF6
KEGG_2021_Human	Tuberculosis	7/180	2.755110571231994e-10	4.484830993122538e-09	106.48362235067438	-315.2928367464337	IFNA1;MYD88;NFKB1;TLR2;TLR4;TLR9;TRAF6
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	6/89	3.0578393134926396e-10	4.484830993122538e-09	144.30722891566265	-386.07102019255314	MYD88;NFKB1;TLR2;TLR4;TLR9;TRAF6
KEGG_2021_Human	Chagas disease	6/102	7.046291742066198e-10	8.85819533288322e-09	124.5625	-348.54374361636394	MYD88;NFKB1;TLR2;TLR4;TLR9;TRAF6
KEGG_2021_Human	Influenza A	6/172	1.671886438631681e-08	1.6382637440568983e-07	71.40361445783132	-227.05657761700246	IFNA1;MYD88;NFKB1;TLR3;TLR4;TLR7
KEGG_2021_Human	Leishmaniasis	5/77	1.6754970109672824e-08	1.6382637440568983e-07	111.05555555555556	-285.8634456707051	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Human immunodeficiency virus 1 infection	6/212	5.8589469438652016e-08	5.097958329198841e-07	57.24757281553398	-189.0900420011584	IFNA1;MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Lipid and atherosclerosis	6/215	6.372447911498552e-08	5.097958329198841e-07	56.40430622009569	-186.7350241167357	IFNA1;MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Toxoplasmosis	5/112	1.1171098780714114e-07	8.192139105857018e-07	74.40186915887851	-210.55667833010622	MYD88;NFKB1;TLR2;TLR4;TRAF6
KEGG_2021_Human	Salmonella infection	6/249	1.5298853524997396e-07	1.0356147001536698e-06	48.30246913580247	-163.50255926584217	MYD88;NFKB1;TLR2;TLR4;TLR9;TRAF6
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	1.6683422435217266e-06	116.26086956521739	-240.55570695978312	MYD88;TLR2;TLR4;TLR9
KEGG_2021_Human	Herpes simplex virus 1 infection	7/498	3.3127242426844717e-07	1.943464889041557e-06	36.00746775288527	-125.29269699884674	IFNA1;MYD88;NFKB1;TLR2;TLR3;TLR9;TRAF6
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	2.4934033250581135e-06	100.81761006289308	-216.95395722754864	MYD88;NFKB1;TLR2;TLR4
KEGG_2021_Human	NOD-like receptor signaling pathway	5/181	1.2298084205616124e-06	6.3660671182012875e-06	44.84090909090909	-138.94613864677578	IFNA1;MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	7.058161648964108e-06	74.03703703703704	-172.05130589538587	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Neutrophil extracellular trap formation	5/189	1.5239212651172506e-06	7.058161648964108e-06	42.84782608695652	-133.62150792773807	HDAC6;NFKB1;TLR2;TLR4;TLR7
KEGG_2021_Human	Epstein-Barr virus infection	5/202	2.1180989596916704e-06	9.31963542264335e-06	39.954314720812185	-125.75142714199099	IFNA1;MYD88;NFKB1;TLR2;TRAF6
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	5.130876847568527e-06	2.1500817266001443e-05	53.12	-132.3420645012429	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	6.145495338330123e-05	39.774436090225564	-104.03256013781805	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Hepatitis C	4/157	2.633008128708365e-05	0.00010074118057666788	34.4880174291939	-91.97557482769783	IFNA1;NFKB1;TLR3;TRAF6
KEGG_2021_Human	Inflammatory bowel disease	3/65	5.7322256772471596e-05	0.0002101816081657292	55.34101382488479	-100.98537671170521	NFKB1;TLR2;TLR4
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00022605056592292776	27.202072538860104	-74.37625984844887	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.000242346918364353	51.17910447761194	-94.92366080084827	IFNA1;NFKB1;TRAF6
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0004971053982039628	21.55922865013774	-59.801482853342776	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0006912554986876636	34.497835497835496	-68.58379435140506	NFKB1;TLR2;TLR4
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.0018724017190416384	14.700952380952382	-40.688114366493096	IFNA1;NFKB1;TLR2;TLR4
KEGG_2021_Human	Necroptosis	3/159	0.0008112107732862489	0.0023795516016396636	21.736263736263737	-45.441996978119036	IFNA1;TLR3;TLR4
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.0025482415917299993	57.378571428571426	-64.24352876962546	MYD88;TLR9
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.003914803502520576	17.769924812030077	-37.496518500419114	IFNA1;NFKB1;TLR3
KEGG_2021_Human	Cytosolic DNA-sensing pathway	2/63	0.00258752682682323	0.00690007153819528	32.8155737704918	-41.182346051003734	IFNA1;NFKB1
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.012251373385729595	11.45360824742268	-23.841254126382374	MYD88;NFKB1;TRAF6
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.013494112232755586	21.914835164835164	-29.03004575134454	TLR2;TLR4
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.013494112232755586	22.16111111111111	-29.32328202848766	NFKB1;TRAF6
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.013494112232755586	21.67391304347826	-28.742216935482162	NFKB1;TRAF6
KEGG_2021_Human	Human papillomavirus infection	3/331	0.006599251035795172	0.015282476082894082	10.113240418118467	-20.757683091358754	IFNA1;NFKB1;TLR3
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.017069218924554073	18.600467289719628	-24.98176436194636	NFKB1;TLR4
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.019720831987131406	16.98931623931624	-22.939511285821055	NFKB1;TRAF6
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.02180967170699673	15.886	-21.510038502238015	NFKB1;TRAF6
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.03003650619825433	13.196666666666667	-17.909946150058477	TLR2;TLR4
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.048978789499594014	6.12012987012987	-11.164029011261546	IFNA1;NFKB1;TRAF6
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.04932007373831106	9.784825870646767	-13.073912909097736	HDAC6;NFKB1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.04932007373831106	9.685960591133005	-12.928804077098514	TLR2;TLR4
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.05738235228992622	8.794843049327355	-11.607417281005194	IFNA1;NFKB1
KEGG_2021_Human	Cocaine addiction	1/49	0.05906133610748362	0.11058292717996933	18.564814814814813	-10.829316375605623	NFKB1
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.11685879121612221	17.128205128205128	-10.081098986019231	IFNA1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.14113439368574746	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.14113439368574746	13.47138047138047	-8.082458738692866	NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.14113439368574746	13.071895424836601	-7.854937277937848	NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.14113439368574746	12.880837359098228	-7.74542097629872	NFKB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.14706751312144253	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.14706751312144253	11.841481481481482	-7.141387005986298	NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.15346838344226188	11.094444444444445	-6.698191160265787	NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.17016019041948052	9.739926739926739	-5.8737398650795125	NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.1754231865488031	8.592233009708737	-5.152341092635986	NFKB1
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.1754231865488031	9.226851851851851	-5.553951626329874	NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.1754231865488031	8.94388327721661	-5.375723879218761	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.11939326812281527	0.1754231865488031	8.764576457645765	-5.262086311101535	NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.1754231865488031	8.592233009708737	-5.152341092635986	NFKB1
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.1759986412668931	8.345911949685535	-4.994589105830365	NFKB1
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1759986412668931	8.2668743509865	-4.943743954376122	NFKB1
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.17926982613878026	7.964964964964965	-4.748494648054986	NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.18682246182781975	7.4858757062146895	-4.435243302362896	NFKB1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.19821013989262115	6.7846153846153845	-3.968927686510734	IFNA1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.19821013989262115	6.892361111111111	-4.041189892105298	NFKB1
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.20152803744019446	6.2466509062253746	-3.6047270952512624	NFKB1
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.16048249753809815	0.20152803744019446	6.338129496402877	-3.6670604531534	TRAF6
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.20152803744019446	6.480392156862745	-3.763669230249352	TRAF6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.20152803744019446	6.384863123993559	-3.698840756963446	NFKB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.21368419881397893	5.70995670995671	-3.235678410841787	NFKB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.21368419881397893	5.672401433691756	-3.209640069203435	NFKB1
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.2181857478075985	5.456866804692892	-3.0596637281364782	IFNA1
KEGG_2021_Human	Alcoholism	1/186	0.20790875456503763	0.24394627202297747	4.734534534534535	-2.5504914662503393	HDAC6
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2444726720856773	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.2444726720856773	4.5823152995927865	-2.441961042053517	NFKB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.25363872142053745	4.326732673267327	-2.2588473265567357	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.26447468300404775	4.058397932816537	-2.065502377074288	NFKB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.26447468300404775	4.001019367991845	-2.0240281738454993	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.27476635992947407	3.7696007696007694	-1.8563524399324505	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2595523897792453	0.27854402805577544	3.6554621848739495	-1.7734497985532327	NFKB1
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2881178347021157	3.4603806994245243	-1.6315316807371463	TRAF6
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3256086876625398	2.9380196523053668	-1.2513063817932166	IFNA1
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.33541860061595846	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3779317125825856	2.32487922705314	-0.8103995559567543	NFKB1
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3779317125825856	2.3584328129782675	-0.8341701676241932	HDAC6
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	NFKB1
